DK0434094T3 - Fremgangsmåder til anvendelse af 2-isopropyl-2-phenylaminovaleronitriler som immunosuppressorer og vasodilatatorer - Google Patents
Fremgangsmåder til anvendelse af 2-isopropyl-2-phenylaminovaleronitriler som immunosuppressorer og vasodilatatorerInfo
- Publication number
- DK0434094T3 DK0434094T3 DK90125244.5T DK90125244T DK0434094T3 DK 0434094 T3 DK0434094 T3 DK 0434094T3 DK 90125244 T DK90125244 T DK 90125244T DK 0434094 T3 DK0434094 T3 DK 0434094T3
- Authority
- DK
- Denmark
- Prior art keywords
- immunosuppressors
- isopropyl
- cyclosporin
- phenylaminovaleronitriles
- vasodilators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
- C07C255/43—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45600789A | 1989-12-21 | 1989-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0434094T3 true DK0434094T3 (da) | 1993-08-16 |
Family
ID=23811068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90125244.5T DK0434094T3 (da) | 1989-12-21 | 1990-12-21 | Fremgangsmåder til anvendelse af 2-isopropyl-2-phenylaminovaleronitriler som immunosuppressorer og vasodilatatorer |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0434094B1 (de) |
JP (1) | JPH04210632A (de) |
AT (1) | ATE87614T1 (de) |
CA (1) | CA2033038A1 (de) |
DE (1) | DE69001240T2 (de) |
DK (1) | DK0434094T3 (de) |
ES (1) | ES2054207T3 (de) |
GR (1) | GR3008320T3 (de) |
IE (1) | IE64870B1 (de) |
PT (1) | PT96283A (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100190852A1 (en) | 2007-06-20 | 2010-07-29 | Milestone Pharmaceuticals Inc. | Short acting phenylalkylamine calcium channel blockers and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3642331A1 (de) * | 1986-12-11 | 1988-06-23 | Basf Ag | Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel |
-
1990
- 1990-12-20 PT PT96283A patent/PT96283A/pt not_active Application Discontinuation
- 1990-12-20 IE IE462790A patent/IE64870B1/en not_active IP Right Cessation
- 1990-12-21 DK DK90125244.5T patent/DK0434094T3/da active
- 1990-12-21 ES ES90125244T patent/ES2054207T3/es not_active Expired - Lifetime
- 1990-12-21 AT AT90125244T patent/ATE87614T1/de not_active IP Right Cessation
- 1990-12-21 CA CA002033038A patent/CA2033038A1/en not_active Abandoned
- 1990-12-21 DE DE9090125244T patent/DE69001240T2/de not_active Expired - Fee Related
- 1990-12-21 JP JP2419052A patent/JPH04210632A/ja not_active Withdrawn
- 1990-12-21 EP EP90125244A patent/EP0434094B1/de not_active Expired - Lifetime
-
1993
- 1993-06-30 GR GR930400669T patent/GR3008320T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0434094B1 (de) | 1993-03-31 |
GR3008320T3 (de) | 1993-09-30 |
DE69001240T2 (de) | 1993-08-05 |
IE904627A1 (en) | 1991-07-17 |
DE69001240D1 (de) | 1993-05-06 |
ES2054207T3 (es) | 1994-08-01 |
IE64870B1 (en) | 1995-09-20 |
EP0434094A1 (de) | 1991-06-26 |
PT96283A (pt) | 1991-09-30 |
JPH04210632A (ja) | 1992-07-31 |
ATE87614T1 (de) | 1993-04-15 |
CA2033038A1 (en) | 1991-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69430951T2 (de) | Zusammensetzung enthaltend bradykinin zum selektiven offnen von anormalen gehirngewebes kapillaren | |
DK0735890T3 (da) | Blandinger af 2',3'-dideoxyinosin og hydroxycarbamid til hæmning af retroviral spredning | |
ATE105482T1 (de) | Behandlung von krebs mit somatostatin und mit analogen davon. | |
DE68915834D1 (de) | Herstellung von T-Zellen und T-Zellmembranen, verwendbar zur Verhütung und Behandlung von Autoimmunkrankheiten. | |
DK0387867T3 (da) | Præparat indeholdende D-cycloserin og D-alanin til forbedring af hukommelse og indlæringsevne eller til behandling af en kognitiv eller psykotisk lidelse | |
DE69525151T2 (de) | Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat | |
EE9700225A (et) | Meetod diabetes mellituse raviks, kasutades KKF | |
DE69010162T2 (de) | Zusammensetzung zur Behandlung von Entzündung. | |
DK71387A (da) | Terapeutisk middel til behandling af psoriasis | |
DK0572688T3 (da) | Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi | |
DE3480901D1 (de) | Haarbehandlungsmittel. | |
ATE152621T1 (de) | Behandlungsverfahren kataboler dysfunktion | |
ATE133663T1 (de) | Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol | |
DK502087A (da) | Bindingsinducerende praeparat og fremgangsmaade til inducering af binding mellem dele af levende mineraliseret vaev | |
NO894222D0 (no) | Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder. | |
IT1135158B (it) | Procedimento di iniezione e di formazione della miscela,come pure dispositivo per la realizzazione dello stesso | |
DK472688D0 (da) | Anvendelse af bezafibrat til behandling af diabetes | |
DK0434094T3 (da) | Fremgangsmåder til anvendelse af 2-isopropyl-2-phenylaminovaleronitriler som immunosuppressorer og vasodilatatorer | |
NO20001758L (no) | FremgangsmÕter og blandinger for behandling av leddgikt | |
DK0504307T3 (da) | Fremgangsmåde til behandling af septisk shock | |
DK381085A (da) | Fremgangsmaade og middel til bekaempelse af luseangreb | |
DE68916777D1 (de) | Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis. | |
NO893224L (no) | Fremgangsmaate for anrikning av vann med oksygen. | |
DK0458537T3 (da) | Anvendelse af en terapeutisk forbindelse til behandling af bronkitis | |
ATE41927T1 (de) | Phenylalkylamine - bioregulatoren. |